Operating out of our St. Louis, MO office, Scott guides our team in integrating strategic and therapeutic insights into our forecast models. He has over 25 years of experience at both large and specialty pharmaceutical companies.
Scott provides objective thought leadership and close collaboration as he guides our clients through forecasting processes across the complete commercial lifecycle. His commercial responsibilities included management of a broad portfolio of products, covering three therapeutic franchises and 28 distinct brands. Scott has also conducted commercial assessments for acquisition and pipeline candidates in all major market segments and participated in five acquisitions. Prior to joining Viscadia, Scott served in a variety of commercial roles at:
- Ther-Rx Corporation (now AMAG)
- Abbott Laboratories (now AbbVie)
Scott views the forecast as both a vital planning resource and a performance measurement tool. He is dedicated to building precisely calibrated forecasts that integrate strategic and therapeutic insights to support stakeholder alignment and help business leaders confidently answer tough questions.
- Strategic Planning and Business Analysis
- Commercial Strategy
- Marketing and Sales Leadership
- Genetic Conditions
- Rare and Orphan Diseases
- BS in Management, University of Missouri, Columbia